Gandasari Ekasatya is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1994. Gandasari Ekasatya is a prominent player in the Indonesian pharmaceutical industry, known for its commitment to quality and innovation. The company was founded by a group of visionary entrepreneurs who aimed to address the growing healthcare needs in Indonesia. Over the years, Gandasari Ekasatya has expanded its operations to include a wide range of pharmaceutical products, focusing on both prescription and over-the-counter medications. The company operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. Gandasari Ekasatya's product portfolio includes a variety of therapeutic categories, such as antibiotics, analgesics, and cardiovascular drugs, under well-recognized brand names. In addition to its domestic operations, Gandasari Ekasatya has established a footprint in select international markets, exporting its products to neighboring countries in Southeast Asia. The company is actively involved in partnerships with local healthcare providers and international pharmaceutical firms to enhance its research and development capabilities. Gandasari Ekasatya is a member of several industry associations, which helps it stay abreast of global pharmaceutical trends and regulatory standards. The company is committed to sustainable practices and aims to contribute to the improvement of public health through its innovative solutions. With a vision to become a leading pharmaceutical company in the region, Gandasari Ekasatya focuses on delivering high-quality healthcare products and services, driven by a mission to improve the quality of life for communities it serves.
Headquarters
Kota Jakarta Barat Kemanggisan Palmerah Dki Jakarta
West Jakarta; Jakarta;
Postal Code: 11480
Contact Details: Purchase the PT Gandasari Ekasatya report to view the information.
Website: http://www.gandasari-ekasatya.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service